Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katelyn J Noronha

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Elife|November 8, 2018
Light-dependent pathways for dopaminergic amacrine cell development and functionTeona Munteanu, Katelyn J Noronha, Amanda C Leung, et al.
Structure (London, England : 1993)|October 15, 2024
PARG inhibition induces nuclear aggregation of PARylated PARP1Sateja Paradkar, Julia Purcell, Annie Cui, et al.
Molecular Cancer Therapeutics|May 1, 2024
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT InhibitorsMatthew A Murray, Katelyn J Noronha, Yazhe Wang, et al.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Elife|November 8, 2018
Light-dependent pathways for dopaminergic amacrine cell development and functionTeona Munteanu, Katelyn J Noronha, Amanda C Leung, et al.
Structure (London, England : 1993)|October 15, 2024
PARG inhibition induces nuclear aggregation of PARylated PARP1Sateja Paradkar, Julia Purcell, Annie Cui, et al.
Molecular Cancer Therapeutics|May 1, 2024
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT InhibitorsMatthew A Murray, Katelyn J Noronha, Yazhe Wang, et al.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 1